Sun Pharmaceutical Industries has been included in the S&P Global Sustainability Yearbook 2024. Within respective industries, this Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability.
This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses. Based on the S&P Global Corporate Sustainability Assessment (CSA) for 2023, over 9,400 companies were assessed for The Sustainability Yearbook 2024. Out of these, 739 companies have qualified for inclusion in The Sustainability Yearbook 2024 globally.
Sun Pharmaceutical Industries is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1508.40 |
Dr. Reddys Lab | 6332.85 |
Cipla | 1424.40 |
Zydus Lifesciences | 992.00 |
Lupin | 1663.00 |
View more.. |